Active Ingredient(s): Oxybutynin Chloride
FDA Approved: * January 27, 2009
Pharm Company: * WATSON LABS
Category: Anticholinergic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Gelnique Overview

Oxybutynin, sold as under the brand names Ditropan among others, is a medication used to treat overactive bladder.[1] It works similar to tolterodine, Darifenacin, and Solifenacin.[1] While used for bed wetting in children, evidence to support this use is poor.[1] It is taken by mouth or applied to the skin.[1] Common side effects include dry mouth, dizziness, constipation, trouble sleeping, and urinary tract infections.[...

Read more Gelnique Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Gelnique Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Oxybutynin Chloride
  • Film, Extended Release: 2.6mg, 3.9mg/24hr
  • Gel: 10%, 10% (100mg/packet), 10%(100mg/packet), 3%
  • Gel, Metered: 3%
  • Syrup: 5mg/5ml
  • System: 3.9mg
  • Tablet: 5mg
  • Tablet, Extended Release: 10mg, 15mg, 5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Gelnique: (5 results)

Sorted by National Drug Code
  • 0023-5812 Gelnique 100 mg/g Transdermal Gel by Allergan, Inc.
  • 0023-5861 Gelnique 100 mg/g Transdermal Gel by Allergan, Inc.
  • 52544-041 Gelnique 28 mg/.92g Transdermal Gel by Watson Pharma, Inc.
  • 52544-084 Gelnique 100 mg/g Transdermal Gel by Watson Pharma, Inc.
  • 54868-6171 Gelnique 100 mg/g Transdermal Gel by Physicians Total Care, Inc.

Other drugs which contain Oxybutynin Chloride or a similar ingredient: (6 results)